Protection of Subjects Participating in Clinical Trials
Clinical trials constitute one of the final stages along the testing continuum that is so needed for the introduction of new products, methods, and ground-breaking technologies. Currently, most economies have recognized the importance clinical trials play as part of the entire value chain from idea to product. While most jurisdictions have developed systems of safeguards for the protection of human subjects involved in clinical trials, there are huge disconnects among jurisdictions, institutions and investigators. This article provides some generally accepted international standards and guidelines in relation to subject protection as it pertains to recruitment, confidentiality, monitoring, data storage and data transfer. The need for all trial protocols to be reviewed by a qualified and registered ethics committee, as well as that all legal requirements are met to ensure patient protection, is also highlighted. Since governments and industry see clinical trials as a critical and necessary step in the product development process, there is a need for more translational research, which will increase the demand for more participation in clinical trials. This article will therefore, also address the importance of patient protection if we are to meet these requirements.
KeywordsPersonal Information Ethical Principle Clinical Trial Design Clinical Trial Registration Patient Protection
The authors acknowledge the support of the St. Boniface Hospital Research Foundation.
- 1.World Medical Association Declaration of Helsinki (2012) Ethical principles for medical research involving human subjects. http://www.wma.net/en/30publications/10policies/b3/. Accessed 19 Oct 2012
- 2.The international conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. http://www.ich.org. Accessed 19 Oct 2012
- 5.US Department of Health and Social Services (1979) Belmont Report. http://www.hhs.gov/ohrp/policy/belmont.html. Accessed 19 Oct 2012
- 6.Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, Social Sciences and Humanities Research Council of Canada (2010) Tri-Council-Policy Statement: Ethical Conduct for Research Involving Humans (2010) http://www.pre.ethics.gc.ca/eng/policy-politique/initiatives/tcps2-eptc2/Default/. Accessed 24 Oct 2012
- 7.Ministry of Health and Family Welfare (2005) Drugs and cosmetics (II Amendment) rules. http://www.drugscontrol.org/Schedule_Y.pdf. Accessed 19 Oct 2012
- 9.Spilker B (1991) Ethical considerations and issues. In: Guide to clinical trials. Raven Press, New York, pp 245–257Google Scholar
- 12.Mahaluxmiwala N (2010) Human subject protection in India: is it adequate? Perspect Clin Res 1:15–20Google Scholar
- 13.European Parliament Policy Department (2009) Clinical trials in developing countries: how to protect people against unethical practices? http://somo.nl/publications-en/Publication_3035. Accessed 22 Oct 2012